Verrucous Carcinoma — Trials

Verrucous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: ECOG-ACRIN Cancer Research Group
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 51–58 of 58 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01674374	Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy	withdrawn	Phase 2	0	Roswell Park Cancer InstituteOTHER	0	May 15, 2013	clinicaltrials
NCT00089362	Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Apr 10, 2013	clinicaltrials